Abstract
Interventions aimed at improving dermatologic conditions have been a hot area of research in recent months. FDA has approved novel agents for the management of metastatic basal cell carcinoma and actinic keratosis, and researchers have focused on the use of alternative therapies, off-label use of FDA-approved agents, and on the efficacy and safety of investigational agents for management of select dermatologic conditions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
